Generate a tailored SOP for Dr. Mary Rezk Hanna. Improve your application with a focused, well-structured draft.
Mary Rezk-Hanna brings a global perspective to her research focusing on the intersection of cardiovascular physiology, tobacco product science, and public health policy. Her work investigates vascular regulation and the short- and long-term cardiovascular responses to novel combustible tobacco products and electronic nicotine delivery systems, including vaping. She leads translational human studies that combine real-time vascular imaging with targeted biomarker analysis to elucidate the mechanisms of tobacco-related vascular harm. Additionally, she conducts secondary analyses of nationally representative surveys, including the Population Assessment of Tobacco Health Study, to understand tobacco use patterns, cardiovascular risk, and disparities among high-risk groups. Her research aims to provide objective evidence that informs FDA regulatory strategies, tobacco control policy, and public health prevention campaigns, particularly concerning flavored tobacco products. Mary has contributed to significant American Heart Association scientific policy statements and has held leadership roles in various health-related initiatives, emphasizing the impact of tobacco and nicotine use on national cardiovascular health surveillance. She is a board-certified nurse practitioner, enhancing the clinical relevance of her scientific endeavors.
Department of Economics admits primarily for the PhD program.